Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: AIDS. 2022 Aug 12;36(15):2101–2106. doi: 10.1097/QAD.0000000000003356

Table 1.

Significant Reactome pathways with associated HitGenes.

REACTOME PATHWAY FDR HITGENES
ADAPTIVE IMMUNE SYSTEM 3.06E-14 TRAC, TRBC1, HLA-DOA, HLA-DOB, LAG3, PRKCB, BTK, BLK, DAPP1, RASGRP2, CD1C, RASGRP1, CD79B, INPP5D, CD19, SLAMF6, ICOS, SH2D1A, NFATC1, PTPRC, CD28, HLA-DRA, CD22, ITK, CD40, PIK3CD, CD3G, CD3E, ITGAL, CD3D, ZAP70, LCK, EVL, WAS, FYB, HLA-DMA, HLA-DMB, KLRG1, CD74, CD247, PDCD1, CLEC2D
GENERATION OF SECOND MESSENGER MOLECULES 1.53E-13 TRAC, TRBC1, HLA-DRA, ITK, CD3G, CD3E, CD3D, ZAP70, LCK, EVL, WAS, FYB, CD247
TCR SIGNALING 7.16E-10 TRAC, TRBC1, INPP5D, PTPRC, HLA-DRA, ITK, CD3G, CD3E, CD3D, ZAP70, LCK, EVL, WAS, FYB, CD247
TRANSLOCATION OF ZAP-70 TO IMMUNOLOGICAL SYNAPSE 1.02E-09 TRAC, TRBC1, HLA-DRA, CD3G, CD3E, CD3D, ZAP70, LCK, CD247
PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS 1.82E-09 TRAC, TRBC1, PTPRC, HLA-DRA, CD3G, CD3E, CD3D, LCK, CD247
CYTOKINE SIGNALING IN IMMUNE SYSTEM 1.82E-09 TNF, TNFRSF4, GBP5, EBI3, GATA3, INPP5D, TNFRSF9, LCN2, HLA-DRA, CIITA, CD40, PIK3CD, CXCL1, TNFRSF13C, JAK3, FCER2, LCK, LTA, LCP1, LTB, BIRC3, CCL4, IL21R, IL12RB1, GBP4, NOS2, CCL20, BATF, IL2RB, PTPN7
PD-1 SIGNALING 2.02E-09 TRAC, TRBC1, HLA-DRA, CD3G, CD3E, CD3D, LCK, CD247, PDCD1
COSTIMULATION BY THE CD28 FAMILY 2.52E-08 TRAC,T RBC1, ICOS, CD28, HLA-DRA, CD3G, CD3E, CD3D, LCK, CD247, PDCD1
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON-LYMPHOID CELL 3.67E-07 TRAC, TRBC1, CD1C, CD19, SLAMF6, SH2D1A, CD22, CD40, CD3G, CD3E, ITGAL, CD3D, KLRG1, CD247, CLEC2D
SIGNALING BY INTERLEUKINS 8.50E-06 TNF, EBI3, GATA3, INPP5D, LCN2, PIK3CD, CXCL1, JAK3, FCER2, LCK, LCP1, CCL4, IL21R, IL12RB1, NOS2, CCL20, BATF, IL2RB, PTPN7
TNF RECEPTOR SUPERFAMILY (TNFSF) MEMBERS MEDIATING NON-CANONICAL NF-KB PATHWAY 3.16E-05 CD40, TNFRSF13C, LTA, LTB, BIRC3
DOWNSTREAM TCR SIGNALING 4.49E-05 TRAC, TRBC1, INPP5D, HLA-DRA, CD3G, CD3E, CD3D, LCK, CD247
INTERLEUKIN-2 FAMILY SIGNALING 1.82E-04 INPP5D, PIK3CD, JAK3, LCK, IL21R, IL2RB
TNFR2 NON-CANONICAL NF-KB PATHWAY 2.65E-04 TNF, TNFRSF4, TNFRSF9, CD40, TNFRSF13C, LTA, LTB, BIRC3
SIGNALING BY THE B CELL RECEPTOR (BCR) 3.48E-04 PRKCB, BTK, BLK, DAPP1, RASGRP1, CD79B, CD19, NFATC1, CD22, PIK3CD
CHEMOKINE RECEPTORS BIND CHEMOKINES 6.22E-04 CXCL1, CXCL3, CXCR4, CXCR6, CCL4, CCL20
INNATE IMMUNE SYSTEM 8.28E-04 C4A, TBC1D10C, BTK, HVCN1, PLD4, RASGRP2, RASGRP1, CD19, LY86, NFATC1, PTPRC, LCN2, ARHGAP9, ITK, CD3G, CXCL1, ITGAL, RAC2, CR1, AIM2, LCK, LTF, BIRC3, WAS, NLRC3, NOS2, CD247
ANTIGEN ACTIVATES B CELL RECEPTOR (BCR) LEADING TO GENERATION OF SECOND MESSENGERS 1.15E-03 BTK, BLK, DAPP1, CD79B, CD19, CD22, PIK3CD
INTERLEUKIN-10 SIGNALING 2.18E-03 TNF, CXCL1, FCER2, CCL4, CCL20
MHC CLASS II ANTIGEN PRESENTATION 2.18E-03 HLA-DOA, HLA-DOB, LAG3, HLA-DRA, HLA-DMA, HLA-DMB, CD74
INTERLEUKIN-4 AND INTERLEUKIN-13 SIGNALING 2.57E-03 TNF, GATA3, LCN2, JAK3, FCER2, NOS2, BATF
INTERLEUKIN RECEPTOR SHC SIGNALING 2.57E-03 INPP5D, PIK3CD, JAK3, IL2RB
INTERLEUKIN-2 SIGNALING 3.67E-03 JAK3, LCK, IL2RB